GDP Inspection Report

The request was successful.

Ewa Franus-Branagan

Dear Medicines and Healthcare products Regulatory Agency,

Could you please send me recent GDP Inspection report for:

Special Products Limited

Yours faithfully,

Ewa Franus-Branagan

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear Enquirer,
 
Thank you for your enquiry to the Medicines and Healthcare products
Regulatory Agency. This automated response confirms that we have received
your email and that it will be dealt with as quickly as possible.
 
You can expect a reply from us within a few days for a straightforward
request, however where a more detailed response or contribution from a
specialist is required this is likely to take longer. We endeavour to
respond to requests within the Department of Health’s target response time
of 18 working days, or 20 working days if your request is a Freedom of
Information request.
 
Our website contains a wealth of information which may assist with your
enquiry. Some of our popular pages are:
 
Clinical trials of medicines and Clinical investigation for a medical
device:
 
[1]https://www.gov.uk/medicines-medical-dev...
       
Manufacturer’s and wholesale dealer’s licences:

[2]https://www.gov.uk/apply-for-manufacture...
 
Registration of medical devices, opticians and dental laboratories:

[3]https://www.gov.uk/register-as-a-manufac...
 
Reporting a problem with a medicine or medical device:

[4]https://www.gov.uk/report-problem-medici...
 
Deciding if your product is a medicine or a medical device:

[5]https://www.gov.uk/decide-if-your-produc...
 
Reporting a counterfeit medical product:
 
[6]https://yellowcard.mhra.gov.uk/counterfe...
 
We are continuously looking to make improvements to the service offered by
our Customer Services team, so if you have any feedback please don’t
hesitate to get in touch with us either on the number below or by
completing the form at the link below:
[7]https://www.surveymonkey.com/s/MHRACusto...
 
If you have not heard from us after 18 working days then please contact us
on 020 3080 6000.
 
Kind regards
 
The Customer Services Team
Communications division
Medicines and Healthcare products Regulatory Agency
 
151 Buckingham Palace Road, London, SW1W 9SZ
Telephone: 020 3080 6000
Email: [8][MHRA request email]
 
Please note this is an automated reply; please do not respond to this
message.
 
 

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 15/401

Dear Ewa Franus-Branagan,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 7th August 2015.

I confirm that your request is being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Kind Regards,

Customer Services
Communications division
Medicines and Healthcare Products Regulatory Agency
151 Buckingham Palace Road, London, SW1W 9SZ
Telephone: 020 3080 6000
Email: [MHRA request email]
Stay connected: mhra.gov.uk/stayconnected

show quoted sections

IE&SFOI, Medicines and Healthcare Products Regulatory Agency

1 Attachment

28th August 2015

Ewa Franus-Branagan

[1][FOI #284696 email]

 

Dear Ewa Franus-Branagan

REF: FOI 15/401

Please find enclosed the relevant information that you requested for
Special Products Limited under the Freedom of Information Act.

 

You will see that some information has been redacted. The relevant
sections of the Freedom of Information Act are marked at the side of each
redaction. These are:

·         Section 40 – This information contains elements of personal
data, the disclosure of which would be unfair in that it would breach the
first principle of the Data Protection Act which says that information
must be processed fairly and lawfully.

·         Section 43 – Release of all, or part of, the information would,
or would be likely to, cause harm to the third party's commercial
interests.

I have considered the balance of the public interest when applying this
exemption. The exemption is to safeguard the commercially sensitive
information / industrial secrets of a third party / commercial enterprise
(which can include a Government Department). This exemption is conditional
on the public interest in releasing it not outweighing the
company's/commercial enterprise's right to confidentiality and the
probable damage that the company/commercial enterprise could suffer as a
result of the information being released. In this case I have not
identified any issues which would benefit the public as a whole by being
brought to their attention (examples of issues would be a major public
health risk or a major procedural failure or irregularity) .

If you have a query about this letter, please do not hesitate to contact
me at [2]IE&[email address]

If you are unhappy with our decision, you may ask for it to be reviewed.
That review will be undertaken by a senior member of the Agency who has
not previously been involved in your request. If you wish to pursue that
option please write to the Communications Directorate, Medicines and
Healthcare products Regulatory Agency, 151 Buckingham Palace Road, London,
SW1W 9SZ.

After that, if you remain dissatisfied, you may write to the Information
Commissioner at;

The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

They will make a decision on whether or not we have interpreted the FOIA
correctly in handling your request.

 

Yours sincerely

Grace Perry

 

MHRA

Inspection, Enforcement and Standards

cc Policy Manager

Copyright notice

The information supplied in response to your request is the copyright of
MHRA and/or a third party or parties, and has been supplied for your
personal use only. You may not sell, resell or otherwise use any
information provided without prior agreement from the copyright holder.
For full details on our copyright policy please visit:

[3]http://www.mhra.gov.uk/home/Idcplg?IdcSe... or
e-mail the [4]MHRA Information Centre

 

 

show quoted sections